← Eichor
Study identifier: NCT07118306 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

COPD Exacerbation Follow Up

Condition: COPD (Chronic Obstructive Pulmonary Disease)  ·  Sponsor: Viz.ai, Inc.

PhaseN/A
Planned participants485
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (4)

Advocate Lutheran General HospitalPark Ridge, Illinois, United StatesNot Yet Recruiting
Cooper University Health CareCherry Hill, New Jersey, United StatesRecruiting
Thomas Jefferson UniversityPhiladelphia, Pennsylvania, United StatesRecruiting
Aurora St. Luke's Medical CenterMilwaukee, Wisconsin, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07118306